Interpretation of long-term overall survival from the PRODIGE 23 study. Letter to the Editor regarding 'Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial', by T. Conroy et al
- 1Unit of Medical Oncology 2, Azienda Ospedaliera Universitaria Pisana, Pisa.
- 2Unit of Medical Oncology 2, Azienda Ospedaliera Universitaria Pisana, Pisa; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa.
- 3Department of Oncology, University of Turin, Città della Salute e della Scienza di Torino, Turin, Italy.
- 0Unit of Medical Oncology 2, Azienda Ospedaliera Universitaria Pisana, Pisa.
|
August 30, 2024
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.